Edition:
United States

People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

126.26USD
18 Aug 2017
Change (% chg)

$-0.36 (-0.28%)
Prev Close
$126.62
Open
$125.91
Day's High
$126.93
Day's Low
$125.02
Volume
172,896
Avg. Vol
219,265
52-wk High
$129.94
52-wk Low
$87.50

Sabba, Stephen 

Dr. Stephen L. Sabba, M.D. is Independent Director of the Company. He has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P., an investment fund company, since November 2006. Previously he was a Partner and Director of Research with Kilkenny Capital Management, a Chicago-based biomedical hedge fund. Prior to that, Dr. Sabba was Director of Research at Sturza’s Medical Research, and previously was a gastroenterologist and internist in private practice at Phelps Memorial Hospital in North Tarrytown, New York. He received his medical degree from the New York University School of Medicine, and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. He earned a Bachelor of Science degree with honors at Cornell University. Dr. Sabba has served as a member of the board of the directors for QLT, Inc., a leading Canadian biotech company, since June 2012.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 74,205
Long-Term Incentive Plans, USD --
All Other, USD 210,701
Fiscal Year Total, USD 284,906

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich

296,271

Matthew Foehr

2,841,260

John Higgins

5,352,640

Matthew Korenberg

1,966,840

Charles Berkman

1,300,170

Jason Aryeh

279,486
As Of  30 Dec 2016